281
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Adherence to guidelines and effectiveness of inpatient treatment for unipolar depression

, , , &
Pages 103-112 | Received 04 Mar 2011, Accepted 20 Oct 2011, Published online: 05 Dec 2011

References

  • Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, . The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J Am Med Assoc 2003;289(23): 3095–105.
  • Murray CJ, Lopez AD. Evidence-based health policy – lessons from the Global Burden of Disease Study. Science 1996;274(5288):740–3.
  • Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, . Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev 2009(3):CD007954.
  • Rush AJ, Trivedi M, Fava M. Depression, IV: STAR*D treatment trial for depression. Am J Psychiatry 2003;160 (2):237.
  • Kaptchuk TJ. The double-blind, randomized, placebo-controlled trial: gold standard or golden calf? J Clin Epidemiol 2001;54(6):541–9.
  • Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, . Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry 2009;166(5):599–607.
  • Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust 2003;179(8):438–40.
  • Mulder RT, Frampton C, Joyce PR, Porter R. Randomized controlled trials in psychiatry. Part II: their relationship to clinical practice. Aust NZ J Psychiatry 2003;37(3):265–9.
  • Porter R, Frampton C, Joyce PR, Mulder RT. Randomized controlled trials in psychiatry. Part 1: methodology and critical evaluation. Aust NZ J Psychiatry 2003;37(3):257–64.
  • Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002;159(3):469–73.
  • DGPPN, KBV, AWMF, AkdÄ, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW for the guideline group unipolar depression*. S3-Guideline/National Guideline for unipolar depression (in German). Berlin, Düsseldorf: DGPPN, ÄZQ, AWMF; 2009 [cited 2009]; 1 [available from: www.dgppn.de, www.versorgungsleitlinien.de, www.awmf-leitlinien.de.
  • Trivedi MH, Rush AJ, Crismon ML, Kashner TM, Toprac MG, Carmody TJ, . Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry 2004;61(7):669–80.
  • Adli M, Berghofer A, Linden M, Helmchen H, Muller-Oerlinghausen B, Mackert A, . Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm study. J Clin Psychiatry 2002;63(9):782–90.
  • Hiller W, Zaudig M, Mombour W, Bronisch T. Routine psychiatric examinations guided by ICD-10 diagnostic checklists (International Diagnostic Checklists). Eur Arch Psychiatry Clin Neurosci 1993;242(4):218–23.
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71.
  • Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33(6): 766–71.
  • Guy, W. (1976). Clinical Global Impressions (CGI). ECDEU Assessment Manual for Psychopharmacology US Department of Health, Education, and Welfare Publication (ADM) 76–338 (pp. 218–222). Rockville, MD: National Institute of Mental Health.
  • Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983;13(3):595–605.
  • First M, Gibbon M, Spitzer R. Structured Clinical Interview for DSM-IV Axis II Disorders. New York, NY: Biometrics Research Dept, NewYork State Psychiatric Institute; 1996.
  • Fydrich T, Renneberg B, Schmitz B, Wittchen HU. SKID-II – Strukturiertes Klinisches Interview für DSM-IV Achse II: Persönlichkeitsstörungen: Göttingen: Hogrefe; 1997.
  • Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, . World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry 2007;8(2):67–104.
  • Olejnik S, Algina J. Measures of effect size for comparative studies: applications, interpretations, and limitations. Contemp Edu Psychol 2000;25:241–86.
  • Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
  • Hirschfeld RM, Montgomery SA, Aguglia E, Amore M, Delgado PL, Gastpar M, . Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. J Clin Psychiatry 2002;63(9):826–37.
  • Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234–41.
  • DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, . Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62(4):409–16.
  • Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Kronmüller K, . Outcomes of 1014 naturalistically treated inpatients with major depressive episode. Eur Neuropsychopharmacol 2010.
  • Schneider F, Harter M, Brand S, Sitta P, Menke R, Hammer-Filipiak U, . Adherence to guidelines for treatment of depression in in-patients. Br J Psychiatry 2005;187:462–9.
  • Jacobi F, Wittchen HU, Holting C, Hofler M, Pfister H, Muller N, . Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004;34(4):597–611.
  • Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, . Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163(11):1905–17.
  • Schramm E, Schneider D, Zobel I, van Calker D, Dykierek P, Kech S, . Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients. J Affect Disord 2008;109(1–2):65–73.
  • Bauer M, Pfennig A, Linden M, Smolka MN, Neu P, Adli M. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inptients with depression. J Clin Psychopharmacol 2009;29(4):327–33.
  • Gilbert DA, Altshuler KZ, Rago WV, Shon SP, Crismon ML, Toprac MG, . Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms. J Clin Psychiatry 1998;59(7):345–51.
  • Adli M, Bauer M, Rush AJ. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry 2006 1;59(11):1029–38.
  • de Jong-Meyer R, Hautzinger M, Kühner C, Schramm E. Evidenced based guidelines in psychotherapy of affective disorders. Göttingen: Hogrefe; 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.